Prevention and Treatment of Dna Vaccine Encoding Cockroach Allergen Bla G 1 in A Mouse Model of Allergic Airway Inflammation

B. Zhou,M. Ensell,Y. Zhou,U. Nair,J. Glickstein,M. H. Kermany,Q. Cai,C. Cai,W. Liu,Y-P Deng,A. Kakigi,M. Barbieri,M. Mora,S. Kanangat,T. J. Yoo

DOI: https://doi.org/10.1111/j.1398-9995.2011.02727.x

IF: 12.4

2011-01-01

Allergy

Abstract:Background: One-fourth of the US population is sensitized to the German cockroach. Primary German cockroach allergen Bla g 1 is detected in 63% of homes and 52% of childcare facilities in the United States. No effective treatment or vaccination strategies are yet available. Objectives: We evaluated the prophylactic and therapeutic efficacy of a plasmid DNA-mediated vaccination using the Bla g 1 gene in a mouse model of allergic inflammatory airway disease. Methods: A plasmid DNA vector coding for the Bla g 1 allergen controlled by cytomegalovirus promoter was constructed. To estimate the protective efficacy, BALB/c mice were given three injections of plasmid DNABla g 1 prior to sensitization with two priming doses of recombinant Bla g 1 (rBla g 1) antigens, followed by nebulized rBla g 1 challenge. In the therapeutic approach, sensitization was followed by administering Bla g 1 DNA vaccine. Results: Bla g 1 vaccination significantly reduced allergen-induced airway inflammation, even after mice were presensitized and a Th2-dominant response was established. The Bla g 1 vaccination significantly reduced total inflammatory cell infiltrate, eosinophilia, secretion of Th2 cytokines IL-4 and IL-5 in bronchoalveolar lavage fluid, allergen-induced inflammatory infiltrates in the lungs, and Bla g 1-specific IgE in serum upon challenge with rBla g 1. Importantly, Bla g 1 DNA vaccination was able to induce IL-10-secreting regulatory T cells that could suppress the allergen-specific Th2 cells. Conclusion: DNA vaccination showed protective and therapeutic efficacy against a clinically relevant allergen Bla g 1.